Company page

Alvotech

Alvotech is a public company traded under the ticker ALVO in the American market. With a market capitalization of approximately $1.31 billion, Alvotech focuses on developing and manufacturing biosimilars. The company aims to provide high-quality, affordable alternatives to expensive biologic therapies.